Article Details

Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL-23p19 ...

Retrieved on: 2022-07-04 20:29:24

Tags for this article:

Click the tags to see associated articles and topics

Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL-23p19 .... View article details on hiswai:

Excerpt

Details: Category: Antibodies: Published on Monday, 04 July 2022 10:27: Hits: ... IBI112, a novel anti-IL-23p19 monoclonal antibody developed by ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up